 Andrew Bubak
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 3, Human | 20 | 2024 | 332 | 5.320 |
Why?
| | Herpes Zoster | 12 | 2024 | 316 | 3.910 |
Why?
| | Amyloid beta-Peptides | 7 | 2024 | 221 | 3.240 |
Why?
| | Varicella Zoster Virus Infection | 5 | 2024 | 24 | 2.430 |
Why?
| | Aggression | 6 | 2020 | 200 | 2.080 |
Why?
| | Islet Amyloid Polypeptide | 3 | 2021 | 46 | 1.970 |
Why?
| | Serotonin | 6 | 2020 | 323 | 1.970 |
Why?
| | Diptera | 5 | 2020 | 30 | 1.870 |
Why?
| | Astrocytes | 3 | 2020 | 210 | 1.590 |
Why?
| | Arteritis | 2 | 2021 | 28 | 1.300 |
Why?
| | Peptide Fragments | 3 | 2024 | 705 | 1.190 |
Why?
| | Virus Activation | 3 | 2024 | 88 | 1.080 |
Why?
| | Macaca mulatta | 3 | 2024 | 166 | 1.040 |
Why?
| | Virus Diseases | 4 | 2022 | 213 | 1.010 |
Why?
| | Behavior, Animal | 3 | 2019 | 497 | 0.980 |
Why?
| | Stroke | 4 | 2023 | 1133 | 0.950 |
Why?
| | Cytokines | 3 | 2024 | 2084 | 0.850 |
Why?
| | Substance P | 2 | 2020 | 36 | 0.830 |
Why?
| | DNA, Viral | 3 | 2024 | 363 | 0.820 |
Why?
| | Exanthema | 2 | 2022 | 78 | 0.770 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 145 | 0.760 |
Why?
| | Octopamine | 3 | 2016 | 9 | 0.740 |
Why?
| | Adventitia | 1 | 2021 | 40 | 0.720 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2019 | 93 | 0.720 |
Why?
| | Temporal Arteries | 1 | 2021 | 45 | 0.710 |
Why?
| | Giant Cell Arteritis | 1 | 2021 | 49 | 0.710 |
Why?
| | Models, Animal | 2 | 2020 | 384 | 0.700 |
Why?
| | Cerebrovascular Disorders | 1 | 2021 | 96 | 0.690 |
Why?
| | Antibodies, Viral | 3 | 2024 | 624 | 0.690 |
Why?
| | Antigens, Viral | 1 | 2021 | 181 | 0.690 |
Why?
| | Antiviral Agents | 4 | 2022 | 739 | 0.680 |
Why?
| | Amyloid | 1 | 2021 | 87 | 0.670 |
Why?
| | Protein Aggregation, Pathological | 1 | 2020 | 19 | 0.660 |
Why?
| | Receptors, Serotonin | 1 | 2020 | 34 | 0.650 |
Why?
| | Central Nervous System Infections | 1 | 2020 | 35 | 0.650 |
Why?
| | Vascular Remodeling | 1 | 2021 | 190 | 0.640 |
Why?
| | Meningitis | 1 | 2020 | 79 | 0.610 |
Why?
| | Receptors, Neurokinin-1 | 1 | 2018 | 8 | 0.600 |
Why?
| | Dopamine | 3 | 2016 | 303 | 0.590 |
Why?
| | Pseudopodia | 1 | 2018 | 26 | 0.590 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2018 | 123 | 0.580 |
Why?
| | Alzheimer Disease | 1 | 2022 | 559 | 0.520 |
Why?
| | Ants | 1 | 2016 | 25 | 0.520 |
Why?
| | Fibroblasts | 1 | 2021 | 993 | 0.510 |
Why?
| | Spinal Cord | 1 | 2018 | 370 | 0.500 |
Why?
| | MPTP Poisoning | 1 | 2015 | 6 | 0.480 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2015 | 72 | 0.470 |
Why?
| | Dopaminergic Neurons | 1 | 2015 | 68 | 0.440 |
Why?
| | Social Perception | 1 | 2015 | 107 | 0.440 |
Why?
| | Agonistic Behavior | 1 | 2013 | 2 | 0.430 |
Why?
| | Biogenic Monoamines | 1 | 2013 | 16 | 0.420 |
Why?
| | Sex Characteristics | 1 | 2019 | 763 | 0.420 |
Why?
| | Varicellovirus | 2 | 2024 | 17 | 0.410 |
Why?
| | Hippocampus | 1 | 2018 | 894 | 0.410 |
Why?
| | Brain Chemistry | 1 | 2013 | 116 | 0.410 |
Why?
| | Animals | 16 | 2024 | 36850 | 0.380 |
Why?
| | 5-Hydroxytryptophan | 3 | 2019 | 21 | 0.370 |
Why?
| | Herpesviridae Infections | 2 | 2024 | 149 | 0.360 |
Why?
| | Cells, Cultured | 6 | 2021 | 4192 | 0.360 |
Why?
| | Acyclovir | 2 | 2020 | 101 | 0.320 |
Why?
| | Sequence Analysis, RNA | 2 | 2021 | 452 | 0.300 |
Why?
| | Male | 14 | 2024 | 67330 | 0.300 |
Why?
| | Humans | 23 | 2024 | 136803 | 0.280 |
Why?
| | Gene Expression | 3 | 2020 | 1500 | 0.260 |
Why?
| | Host-Pathogen Interactions | 2 | 2020 | 363 | 0.260 |
Why?
| | Chickenpox | 2 | 2024 | 83 | 0.230 |
Why?
| | Trigeminal Ganglion | 1 | 2024 | 25 | 0.230 |
Why?
| | Monkey Diseases | 1 | 2024 | 20 | 0.220 |
Why?
| | Tyramine | 2 | 2013 | 8 | 0.210 |
Why?
| | Herpes Simplex | 1 | 2024 | 95 | 0.210 |
Why?
| | Trigeminal Neuralgia | 1 | 2024 | 18 | 0.210 |
Why?
| | Neuralgia, Postherpetic | 1 | 2024 | 40 | 0.210 |
Why?
| | Herpesvirus 1, Human | 1 | 2024 | 87 | 0.210 |
Why?
| | Sensory Receptor Cells | 1 | 2024 | 98 | 0.210 |
Why?
| | Nerve Block | 1 | 2024 | 73 | 0.200 |
Why?
| | Presenilin-1 | 1 | 2022 | 31 | 0.200 |
Why?
| | Immunoglobulin G | 2 | 2024 | 887 | 0.200 |
Why?
| | Azadirachta | 1 | 2022 | 3 | 0.190 |
Why?
| | Inflammation | 3 | 2022 | 2835 | 0.190 |
Why?
| | Microglia | 1 | 2024 | 251 | 0.190 |
Why?
| | Neuralgia | 1 | 2024 | 133 | 0.190 |
Why?
| | Exosomes | 1 | 2023 | 103 | 0.190 |
Why?
| | Neuroblastoma | 1 | 2023 | 160 | 0.180 |
Why?
| | Viral Proteins | 1 | 2024 | 340 | 0.180 |
Why?
| | Tissue Fixation | 1 | 2021 | 36 | 0.180 |
Why?
| | Paraffin Embedding | 1 | 2021 | 32 | 0.180 |
Why?
| | Olfactory Bulb | 1 | 2022 | 93 | 0.180 |
Why?
| | Plasma | 1 | 2023 | 213 | 0.180 |
Why?
| | Formaldehyde | 1 | 2021 | 63 | 0.180 |
Why?
| | Adrenal Glands | 1 | 2021 | 78 | 0.180 |
Why?
| | Cerebral Amyloid Angiopathy | 1 | 2021 | 11 | 0.180 |
Why?
| | DNA, Complementary | 1 | 2021 | 271 | 0.170 |
Why?
| | Olfactory Receptor Neurons | 1 | 2021 | 41 | 0.170 |
Why?
| | Neuronal Outgrowth | 1 | 2020 | 9 | 0.170 |
Why?
| | TRPM Cation Channels | 1 | 2021 | 74 | 0.170 |
Why?
| | Whole-Body Irradiation | 1 | 2020 | 78 | 0.170 |
Why?
| | Cell Death | 1 | 2022 | 372 | 0.170 |
Why?
| | Cell Movement | 3 | 2019 | 968 | 0.170 |
Why?
| | Intracellular Space | 1 | 2020 | 68 | 0.160 |
Why?
| | Antigens, CD | 2 | 2019 | 521 | 0.160 |
Why?
| | Extracellular Space | 1 | 2020 | 119 | 0.160 |
Why?
| | Protein Aggregates | 1 | 2020 | 72 | 0.160 |
Why?
| | Viral Envelope Proteins | 1 | 2020 | 84 | 0.160 |
Why?
| | Thrombosis | 1 | 2023 | 366 | 0.160 |
Why?
| | Radiosurgery | 1 | 2022 | 344 | 0.160 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 93 | 0.160 |
Why?
| | Tachykinins | 1 | 2019 | 6 | 0.160 |
Why?
| | Receptors, Serotonin, 5-HT2 | 1 | 2019 | 4 | 0.160 |
Why?
| | Corneal Keratocytes | 1 | 2019 | 9 | 0.150 |
Why?
| | Tacrolimus | 1 | 2020 | 199 | 0.150 |
Why?
| | Behavior Observation Techniques | 1 | 2019 | 10 | 0.150 |
Why?
| | Epithelium, Corneal | 1 | 2019 | 41 | 0.150 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2018 | 5 | 0.150 |
Why?
| | Aged | 5 | 2024 | 23808 | 0.150 |
Why?
| | Spiro Compounds | 1 | 2018 | 14 | 0.150 |
Why?
| | Neuropeptides | 1 | 2019 | 73 | 0.150 |
Why?
| | Papillomavirus Infections | 1 | 2022 | 324 | 0.150 |
Why?
| | Female | 8 | 2024 | 72816 | 0.150 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2018 | 100 | 0.150 |
Why?
| | Myofibroblasts | 1 | 2019 | 126 | 0.140 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 327 | 0.140 |
Why?
| | Cadherins | 1 | 2019 | 205 | 0.140 |
Why?
| | Motor Neurons | 1 | 2020 | 234 | 0.140 |
Why?
| | Risk | 1 | 2020 | 908 | 0.140 |
Why?
| | MicroRNAs | 1 | 2024 | 692 | 0.140 |
Why?
| | Multiple Sclerosis | 1 | 2023 | 455 | 0.140 |
Why?
| | Aortic Diseases | 1 | 2018 | 117 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 604 | 0.130 |
Why?
| | Protein Isoforms | 1 | 2018 | 403 | 0.130 |
Why?
| | B7-H1 Antigen | 1 | 2019 | 217 | 0.130 |
Why?
| | Nesting Behavior | 1 | 2016 | 16 | 0.130 |
Why?
| | Touch | 1 | 2016 | 36 | 0.130 |
Why?
| | Neurotransmitter Agents | 1 | 2016 | 82 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 622 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 556 | 0.130 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5750 | 0.130 |
Why?
| | Proteomics | 1 | 2022 | 1109 | 0.120 |
Why?
| | Immunosuppressive Agents | 1 | 2020 | 889 | 0.120 |
Why?
| | Transcriptome | 1 | 2021 | 969 | 0.120 |
Why?
| | Caudate Nucleus | 1 | 2015 | 23 | 0.120 |
Why?
| | Oxygen | 1 | 2020 | 930 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2019 | 778 | 0.120 |
Why?
| | Body Size | 1 | 2015 | 108 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1772 | 0.110 |
Why?
| | RNA, Messenger | 2 | 2020 | 2831 | 0.110 |
Why?
| | Flight, Animal | 1 | 2013 | 18 | 0.110 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2013 | 46 | 0.100 |
Why?
| | Hydroxyindoleacetic Acid | 1 | 2013 | 26 | 0.100 |
Why?
| | Risk Assessment | 1 | 2023 | 3434 | 0.100 |
Why?
| | Competitive Behavior | 1 | 2013 | 43 | 0.100 |
Why?
| | Olfactory Mucosa | 2 | 2024 | 38 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 913 | 0.100 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1455 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2020 | 3540 | 0.100 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2605 | 0.100 |
Why?
| | Data Interpretation, Statistical | 1 | 2013 | 363 | 0.090 |
Why?
| | Middle Aged | 3 | 2024 | 33239 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4282 | 0.080 |
Why?
| | Brain | 2 | 2024 | 2664 | 0.080 |
Why?
| | Biomarkers | 1 | 2020 | 4145 | 0.080 |
Why?
| | Virus Replication | 2 | 2022 | 482 | 0.080 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7593 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2822 | 0.070 |
Why?
| | Mice | 4 | 2024 | 17759 | 0.060 |
Why?
| | Risk Factors | 1 | 2018 | 10332 | 0.050 |
Why?
| | Virus Latency | 1 | 2024 | 82 | 0.050 |
Why?
| | Central Nervous System | 1 | 2024 | 258 | 0.050 |
Why?
| | Limonins | 1 | 2022 | 2 | 0.050 |
Why?
| | Plant Bark | 1 | 2022 | 11 | 0.050 |
Why?
| | Adrenal Cortex | 1 | 2022 | 29 | 0.050 |
Why?
| | Apoptosis | 2 | 2023 | 2552 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 65 | 0.050 |
Why?
| | Primary Cell Culture | 1 | 2022 | 171 | 0.050 |
Why?
| | Adult | 2 | 2024 | 37643 | 0.040 |
Why?
| | Histological Techniques | 1 | 2021 | 40 | 0.040 |
Why?
| | Cerebral Arteries | 1 | 2021 | 59 | 0.040 |
Why?
| | Interleukins | 1 | 2022 | 251 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 403 | 0.040 |
Why?
| | Plant Extracts | 1 | 2022 | 202 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2023 | 327 | 0.040 |
Why?
| | Claudin-1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2019 | 110 | 0.040 |
Why?
| | Programmed Cell Death 1 Ligand 2 Protein | 1 | 2019 | 15 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2020 | 226 | 0.040 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2019 | 50 | 0.040 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 1 | 2019 | 30 | 0.040 |
Why?
| | Electrochemical Techniques | 1 | 2019 | 52 | 0.040 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 99 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2019 | 239 | 0.040 |
Why?
| | Matrix Metalloproteinases | 1 | 2019 | 95 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2020 | 256 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2020 | 247 | 0.030 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 250 | 0.030 |
Why?
| | Action Potentials | 1 | 2020 | 493 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 975 | 0.030 |
Why?
| | Macrophages | 1 | 2024 | 1544 | 0.030 |
Why?
| | Leukocytes, Mononuclear | 1 | 2019 | 558 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2021 | 2163 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2838 | 0.030 |
Why?
| | DNA | 1 | 2021 | 1458 | 0.030 |
Why?
| | Mitochondria | 1 | 2020 | 946 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2019 | 1095 | 0.020 |
Why?
| | RNA | 1 | 2019 | 921 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2023 | 6032 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2476 | 0.020 |
Why?
| | Infant | 1 | 2024 | 9395 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 10997 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13129 | 0.020 |
Why?
| | Adolescent | 1 | 2024 | 21385 | 0.010 |
Why?
| | Child | 1 | 2024 | 21819 | 0.010 |
Why?
|
|
Bubak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|